Search Results - "van Eijs, Mick J. M."

Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance by Verheijden, Rik J., van Eijs, Mick J. M., May, Anne M., van Wijk, Femke, Suijkerbuijk, Karijn P. M.

“…Immune checkpoint inhibitors (ICIs) have changed perspectives for patients with cancer, but come with severe immune-related adverse events (irAEs). To prevent…”
Get full text

Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition by van Eijs, Mick J. M., Verheijden, Rik J., van der Wees, Stefanie A., Nierkens, Stefan, van Lindert, Anne S. R., Suijkerbuijk, Karijn P. M., van Wijk, Femke

“…Immune checkpoint inhibitors (ICI) have revolutionized the treatment landscape of advanced malignancies, but come with a diverse spectrum of immune-related…”
Get full text

In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients by Timmerman, Laura M., Hensen, Lobke C. M., van Eijs, Mick J. M., Verheijden, Rik J., Suijkerbuijk, Karijn P. M., Meyaard, Linde, van der Vlist, Michiel

“…PD-1 blockade therapy has revolutionized melanoma treatment, but still not all patients benefit and pre-treatment identification of those patients is…”
Get full text

Hematologic malignancies following immune checkpoint inhibition for solid tumors by van Eijs, Mick J. M., van der Wagen, Lotte E., Mous, Rogier, Leguit, Roos J., van de Corput, Lisette, van Lindert, Anne S. R., Suelmann, Britt B. M., Kamphuis, Anna M., Nierkens, Stefan, Suijkerbuijk, Karijn P. M.

“…Immune checkpoint inhibition (ICI) can induce durable responses in patients with advanced malignancies. Three cases of hematological neoplasia following ICI…”
Get full text

Innovative Perspective: Gadolinium-Free Magnetic Resonance Imaging in Long-Term Follow-Up after Kidney Transplantation by van Eijs, Mick J M, van Zuilen, Arjan D, de Boer, Anneloes, Froeling, Martijn, Nguyen, Tri Q, Joles, Jaap A, Leiner, Tim, Verhaar, Marianne C

“…Since the mid-1980s magnetic resonance imaging (MRI) has been investigated as a non- or minimally invasive tool to probe kidney allograft function. Despite…”
Get full text

Physical activity and checkpoint inhibition: association with toxicity and survival by Verheijden, Rik J, Cabané Ballester, Anna, Smit, Karel C, van Eijs, Mick J M, Bruijnen, Cheryl P, van Lindert, Anne S R, Suijkerbuijk, Karijn P M, May, Anne M

“…Although animal experiments suggest beneficial effects of physical activity (PA) on antitumor immunity, little is known about the effects of PA on immune…”
Get full text

Clinical and translational attributes of immune-related adverse events by Suijkerbuijk, Karijn P M, van Eijs, Mick J M, van Wijk, Femke, Eggermont, Alexander M M

“…With immune checkpoint inhibitors (ICIs) becoming the mainstay of treatment for many cancers, managing their immune-related adverse events (irAEs) has become…”
Get full text

Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies by Van Not, Olivier J., van den Eertwegh, Alfons J.M., Haanen, John B., van Rijn, Rozemarijn S., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., Blank, Christian U., Boers-Sonderen, Marye J., van Eijs, Mick J.M., de Groot, Jan-Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, de Meza, Melissa, Piersma, Djura, Stevense-den Boer, Marion, van der Veldt, Astrid A.M., Vreugdenhil, Gerard, Wouters, Michel W.J.M., Suijkerbuijk, Karijn P.M., Blokx, Willeke A.M.

“…Patients diagnosed with haematologic malignancies (HMs) have a higher risk of developing subsequent solid tumours, such as melanoma. Patients with HM were…”
Get full text

Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis by van Eijs, Mick J.M., ter Linde, José J.M., Baars, Matthijs J.D., Amini, Mojtaba, Laclé, Miangela M., Brand, Eelco C., Delemarre, Eveline M., Drylewicz, Julia, Nierkens, Stefan, Verheijden, Rik J., Oldenburg, Bas, Vercoulen, Yvonne, Suijkerbuijk, Karijn P.M., van Wijk, Femke

“…Colitis is a prevalent adverse event associated with immune checkpoint inhibitor (ICI) therapy with similarities to inflammatory bowel disease. Incomplete…”
Get full text

Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma by Verheijden, Rik J., Burgers, Femke H., Janssen, Josephine C., Putker, Anouk E., Veenstra, Sophie P.G.R., Hospers, Geke A.P., Aarts, Maureen J.B., Hehenkamp, Karel W., Doornebosch, Veerle L.E., Verhaert, Marthe, van den Berkmortel, Franchette W.P.J., Chatzidionysiou, Katerina, Llobell, Arturo, Barros, Milton, Maria, Alexandre T.J., Takeji, Akari, García Morillo, José-Salvador, Lidar, Merav, van Eijs, Mick J.M., Blank, Christian U., Aspeslagh, Sandrine, Piersma, Djura, Kapiteijn, Ellen, Labots, Mariette, Boers-Sonderen, Marye J., van der Veldt, Astrid A.M., Haanen, John B.A.G., May, Anne M., Suijkerbuijk, Karijn P.M.

“…Recent studies indicate an association between immunosuppression for immune-related adverse events (irAEs) and impaired survival in patients who received…”
Get full text

Association between physical activity, immune-related adverse events, and mortality in patients undergoing immune checkpoint inhibition by Verheijden, Rik Jasper, Cabane Ballester, Anna, van Eijs, Mick JM, van Lindert, Anne SR, Suijkerbuijk, Karijn, May, Anne Maria

“…2643 Background: Immune checkpoint inhibitors (ICIs) have improved prospects for some, but not all patients with cancer and frequently induce severe…”
Get full text

Student-driven education; catalyst of change in medical curriculum by van Eijs, Mick J M, Casteleijn, Romée N, de Weerd, Marleine L, Bos, Sander J J

“…Changing healthcare requires future physicians to have some basic knowledge of fields related to medicine. There is also a growing need for multidisciplinary…”
Get more information